FR3662M - Médicament a base de nouveaux dérivés 1.2.3.6-tétrahydropyridiniques, ayant notamment des propriétés analgésiques et anti-tussives. - Google Patents

Médicament a base de nouveaux dérivés 1.2.3.6-tétrahydropyridiniques, ayant notamment des propriétés analgésiques et anti-tussives.

Info

Publication number
FR3662M
FR3662M FR991817A FR991817A FR3662M FR 3662 M FR3662 M FR 3662M FR 991817 A FR991817 A FR 991817A FR 991817 A FR991817 A FR 991817A FR 3662 M FR3662 M FR 3662M
Authority
FR
France
Prior art keywords
new
product based
medicinal product
tetrahydropyridine derivatives
particular analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR991817A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH905363A external-priority patent/CH425788A/de
Priority claimed from CH905263A external-priority patent/CH423776A/de
Priority claimed from CH932563A external-priority patent/CH426809A/de
Priority claimed from CH932463A external-priority patent/CH426808A/de
Priority claimed from FR982320A external-priority patent/FR1414820A/fr
Application filed by JR Geigy AG filed Critical JR Geigy AG
Priority to FR991817A priority Critical patent/FR3662M/fr
Priority claimed from CH60465A external-priority patent/CH460772A/de
Application granted granted Critical
Publication of FR3662M publication Critical patent/FR3662M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Valves And Accessory Devices For Braking Systems (AREA)
FR991817A 1963-07-19 1964-10-17 Médicament a base de nouveaux dérivés 1.2.3.6-tétrahydropyridiniques, ayant notamment des propriétés analgésiques et anti-tussives. Active FR3662M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR991817A FR3662M (fr) 1963-07-19 1964-10-17 Médicament a base de nouveaux dérivés 1.2.3.6-tétrahydropyridiniques, ayant notamment des propriétés analgésiques et anti-tussives.

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CH905363A CH425788A (de) 1963-07-19 1963-07-19 Verfahren zur Herstellung von neuen Derivaten des 1,2,3,6-Tetrahydro-pyridins
CH905263A CH423776A (de) 1963-07-19 1963-07-19 Verfahren zur Herstellung von neuen Piperidinderivaten
CH932563A CH426809A (de) 1963-07-26 1963-07-26 Verfahren zur Herstellung von neuen Derivaten des 1,2,3,6-Tetrahydro-pyridins
CH932463A CH426808A (de) 1963-07-26 1963-07-26 Verfahren zur Herstellung von neuen Piperidinderivaten
FR982320A FR1414820A (fr) 1963-07-19 1964-07-20 Nouveaux dérivés de la 1, 2, 3, 6-tétrahydro-pyridine et leur préparation
FR991817A FR3662M (fr) 1963-07-19 1964-10-17 Médicament a base de nouveaux dérivés 1.2.3.6-tétrahydropyridiniques, ayant notamment des propriétés analgésiques et anti-tussives.
CH60465A CH460772A (de) 1965-01-15 1965-01-15 Verfahren zur Herstellung von neuen Piperidinderivaten

Publications (1)

Publication Number Publication Date
FR3662M true FR3662M (fr) 1965-11-02

Family

ID=27508864

Family Applications (5)

Application Number Title Priority Date Filing Date
FR991817A Active FR3662M (fr) 1963-07-19 1964-10-17 Médicament a base de nouveaux dérivés 1.2.3.6-tétrahydropyridiniques, ayant notamment des propriétés analgésiques et anti-tussives.
FR991816A Active FR3760M (fr) 1963-07-19 1964-10-17 Médicament a base de dérivés de la 1.2.3.6-tétrahydropyridine, ayant notamment des propriétés analgésiques et anti-tussives.
FR991815A Active FR3759M (fr) 1963-07-19 1964-10-17 Médicament a base de nouveaux dérivés de la pipéridine, ayant notamment une action analgésique et anti-tussive.
FR46020A Expired FR1463646A (fr) 1963-07-19 1966-01-15 Dérivés de la pipéridine et leur préparation
FR57638A Expired FR5343M (fr) 1963-07-19 1966-04-14

Family Applications After (4)

Application Number Title Priority Date Filing Date
FR991816A Active FR3760M (fr) 1963-07-19 1964-10-17 Médicament a base de dérivés de la 1.2.3.6-tétrahydropyridine, ayant notamment des propriétés analgésiques et anti-tussives.
FR991815A Active FR3759M (fr) 1963-07-19 1964-10-17 Médicament a base de nouveaux dérivés de la pipéridine, ayant notamment une action analgésique et anti-tussive.
FR46020A Expired FR1463646A (fr) 1963-07-19 1966-01-15 Dérivés de la pipéridine et leur préparation
FR57638A Expired FR5343M (fr) 1963-07-19 1966-04-14

Country Status (13)

Country Link
US (6) US3366638A (fr)
BE (4) BE650738A (fr)
BR (1) BR6676431D0 (fr)
DE (4) DE1445838A1 (fr)
DK (2) DK114973B (fr)
FI (1) FI46846B (fr)
FR (5) FR3662M (fr)
GB (4) GB1062714A (fr)
IL (1) IL24971A (fr)
MY (1) MY7100123A (fr)
NL (5) NL6408219A (fr)
NO (1) NO121781B (fr)
SE (1) SE327986B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448086A (de) * 1965-01-15 1967-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen Derivaten des 1,2,3,6-Tetrahydro-pyridins
US3523949A (en) * 1967-07-10 1970-08-11 Geigy Chem Corp 4-allyl-1-(2-anilinoethyl)-4-carbalkoxy-piperidines
CH491917A (de) * 1968-01-11 1970-06-15 Geigy Ag J R Verfahren zur Herstellung von neuen Piperidinderivaten
US3679799A (en) * 1970-03-03 1972-07-25 Ciba Geigy Corp Piperdine derivatives in an antitussive composition and method
US3970636A (en) * 1975-04-15 1976-07-20 American Cyanamid Company Tetramethylpiperidinylphosphine oxides as light stabilizers for polymers
DE2720612C2 (de) * 1977-05-07 1987-02-19 Basf Ag, 6700 Ludwigshafen 3,5-Dimethyl-piperidin-4-one
US4166803A (en) * 1978-01-09 1979-09-04 Eastman Kodak Company Heterocyclic benzoate ultraviolet stabilizers and their use in organic compositions
IT1160181B (it) * 1983-01-19 1987-03-04 Montedison Spa Derivati della 4-metil-piperidina alchil-sostituita e loro impiego come stabilizzanti
US4929508A (en) * 1984-10-05 1990-05-29 Warner-Lambert Company Novel drug delivery system for antitussives
US4740560A (en) * 1986-04-17 1988-04-26 The Dow Chemical Company ABS resins and process for making them
ES2074441T3 (es) * 1987-10-05 1995-09-16 Yamanouchi Pharma Co Ltd Compuestos espiro heterociclicos y su preparacion.
WO2001022964A1 (fr) * 1999-09-27 2001-04-05 Georgetown University Inhibiteurs du transporteur de dopamine et leur utilisation
IT1317842B1 (it) * 2000-02-18 2003-07-15 Attilio Citterio Procedimenti di modifica superficiale della silice per elettroforesicapillare e cromatografia.
US8668902B2 (en) * 2006-06-08 2014-03-11 Vapor Shield, Inc. Composition with activated carbon in oral treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081309A (en) * 1963-03-12 Table vi
US3125574A (en) * 1964-03-17 I-aroylpropylx-acyl-x-amino-
US2798073A (en) * 1957-07-02 Piperidine derivatives and preparation
US3029244A (en) * 1959-08-31 1962-04-10 Research Corp Aroylpiperidinols and esters thereof

Also Published As

Publication number Publication date
US3456060A (en) 1969-07-15
DE1445836A1 (de) 1969-01-23
FR3760M (fr) 1965-12-13
DK114622B (da) 1969-07-21
BR6676431D0 (pt) 1973-09-06
FR1463646A (fr) 1966-12-23
GB1062713A (en) 1967-03-22
NL6600523A (fr) 1966-07-18
FI46846B (fr) 1973-04-02
BE675145A (fr) 1966-07-14
NL6408219A (fr) 1965-01-20
NO121781B (fr) 1971-04-13
NL124853C (fr)
FR3759M (fr) 1965-12-13
US3498994A (en) 1970-03-03
BE650737A (fr) 1965-01-18
DK114973B (da) 1969-08-25
BE650736A (fr) 1965-01-18
IL24971A (en) 1969-09-25
GB1062715A (en) 1967-03-22
FR5343M (fr) 1967-09-04
DE1445837A1 (de) 1968-12-19
US3509258A (en) 1970-04-28
US3366638A (en) 1968-01-30
MY7100123A (en) 1971-12-31
SE327986B (fr) 1970-09-07
US3408357A (en) 1968-10-29
DE1445838A1 (de) 1969-04-17
NL6408223A (fr) 1965-01-20
NL6408218A (fr) 1965-01-20
GB1116326A (en) 1968-06-06
GB1062714A (en) 1967-03-22
BE650738A (fr) 1965-01-18
US3338910A (en) 1967-08-29
DE1695054A1 (de) 1972-02-24

Similar Documents

Publication Publication Date Title
FR3662M (fr) Médicament a base de nouveaux dérivés 1.2.3.6-tétrahydropyridiniques, ayant notamment des propriétés analgésiques et anti-tussives.
FR2373M (fr) Nouveaux médicaments a base d'enzymes protéolytiques.
FR3702M (fr) Médicament a base d'anguidine et de ses dérivés.
FR1704M (fr) Médicament anti-allergique et anti-histaminique a base de β-alanine.
FR3293M (fr) Médicament agissant sur le systeme nerveux central et ayant notamment des propriétés anti-anxiété et tranquillisantes a base de nouveaux sulfamides.
NO136364C (no) Selvsluknende polymerprodukt i lateksform.
FR3460M (fr) Médicament présentant notamment des propriétés bradycardisantes a base de o-diéthylamino-éthoxy-2-phényl-2-indole.
FR1807M (fr) Médicament présentant notamment des propriétés sédatives et hypnogenes a base de ω (n-morpholino)p-chloro-acétophénone.
FR1843M (fr) Médicament a base d'amides d'acides 1.4-benzodioxanne-carboxyliques.
FR2955M (fr) Médicament utilisable notamment comme analgésique et hypnotique a base de 4-alcoylamidophénylcarbonates d'haloalcoyle.
BE771112A (fr) Medicament a base d'un derive de l'aminoguanidine
FR1577M (fr) Médicament présentant notamment des propriétés diurétiques et cardiotoniques a base de vitexoside.
FR3310M (fr) Médicament utilisable notamment comme relaxant musculaire et anesthésique local.
FR2816M (fr) Médicament présentant des propriétés cardiotoniques a base d'un extrait d'erysimum allionii.
FR3462M (fr) Médicament utilisable, en particulier, comme spasmolytique et anesthésique local, a base d'ester de cyclohexanol substitué.
FR3580M (fr) Médicament utilisable en particulier comme analgésique et anti-inflammatoire, a base de dérivé du phloroglucinol.
FR1411M (fr) Médicament a propriétés sédatives et d'épargne protidique a base de 4-hydroxy-butyrate de lysine.
FR1143M (fr) Médicament a base de dérivé pyimidique, notamment pour le traitement de l'hypercholestérolémie et de l'hyper-uricémie.
FR2248M (fr) Médicament a base de nouveaux acides octahydrophénanthroiques.
FR2187M (fr) Médicament a base de dérivé d'α-phényl α-éthyl-acétamide doué de propriétés hypocholestérolémiantes et cholérétiques.
FR3640M (fr) 1 pyridil-cyclopropane-2-substitués par des groupements organiques, notamment utiles comme sédatifs, tranquillisants et anti-dépresseurs.
FR244M (fr) Médicament présentant des propriétés antiphlogistiques, analgésiques et antipyrétiques a base de 4-phényl-5-alcoyle -1,3,4-thiadiazolidine-2-thione.
FR3757M (fr) Médicament a base de streptokinase.
FR2326M (fr) Médicament présentant des propriétés anesthesiques locales et antiprurigineuses a base de (&alpha-n-pyrrolidino-benzyl)-phényl-cétone.
FR1644M (fr) Médicament a base d'acides 2-méthoxy-benzoiques.